You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 156 No. 7, 8 APRIL 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  REVIEW ARTICLE
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (109)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease)

New Insights in Pathogenesis, Complications, and Treatment

Tjeerd Haitjema, MD, PhD; Cornelius J. J. Westermann, MD, PhD; Thimotheus T. C. Overtoom, MD; Robin Timmer, MD, PhD; Frans Disch, MD, PhD; Henk Mauser, MD, PhD; Jan-Willem J. Lammers, MD, PhD

Arch Intern Med. 1996;156(7):714-719.


Abstract



Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is a hereditary disorder leading to easily bleeding telangiectases on skin and mucosal surfaces, and it is associated with the presence of arteriovenous malformations (AVMs) in multiple organ systems. These AVMs may cause serious complications when they are located in the lungs, liver, or brain. The prevalence of AVMs in patients with HHT might be higher than previously estimated. Nowadays, treatment is often possible. In some families, mutations have been shown in the gene encoding for a transforming growth factor receptor, endoglin. Genetic heterogeneity has been demonstrated, suggesting involvement of other transforming growth factor receptors. This might explain the variable clinical expression of the disease. In view of the high prevalence of pulmonary and cerebral AVMs, all patients with HHT should be screened for their presence, and relatives of patients with HHT should be investigated for presence of the disease.

(Arch Intern Med. 1996;156:714-719)



Author Affiliations



From the Departments of Pulmonology (Drs Haitjema and Westermann), Radiology (Dr Overtoom), Gastroenterology (Dr Timmer), Otolaryngology (Dr Disch), and Neurology (Dr Mauser), St Antonius Hospital, Nieuwegein, the Netherlands, and the Department of Pulmonology, Academic Hospital, Utrecht, the Netherlands (Dr Lammers).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Endoglin (CD105): A Review of its Role in Angiogenesis and Tumor Diagnosis, Progression and Therapy
NASSIRI et al.
Anticancer Res 2011;31:2283-2290.
ABSTRACT | FULL TEXT  

Late Onset of Hypoxemia Due to a Pulmonary Arteriovenous Malformation During Selective Estrogen Receptor Modulator Therapy
Rapacciuolo et al.
J Am Coll Cardiol 2010;55:e9-e9.
FULL TEXT  

Use of the Microdebrider in Selective Excision of Hereditary Hemorrhagic Telangiectasia: A New Approach
Bublik et al.
Otolaryngol Head Neck Surg 2007;137:157-158.
FULL TEXT  

Acute Visual Loss as the Presenting Complaint of Hereditary Hemorrhagic Telangiectasia
Hackelton
J Am Board Fam Med 2006;19:637-640.
ABSTRACT | FULL TEXT  

Symptomatic Children With Hereditary Hemorrhagic Telangiectasia: A Pediatric Center Experience
Mei-Zahav et al.
Arch Pediatr Adolesc Med 2006;160:596-601.
ABSTRACT | FULL TEXT  

A Pulmonary Right-to-Left Shunt in Patients With Hereditary Hemorrhagic Telangiectasia Is Associated With an Increased Prevalence of Migraine
Post et al.
Chest 2005;128:2485-2489.
ABSTRACT | FULL TEXT  

Capillaroscopy of the dorsal skin of the hands in hereditary hemorrhagic telangiectasia
Pasculli et al.
QJM 2005;98:757-763.
ABSTRACT | FULL TEXT  

Mutation Analysis in Spanish Patients with Hereditary Hemorrhagic Telangiectasia: Deficient Endoglin Up-regulation in Activated Monocytes
Sanz-Rodriguez et al.
Clin. Chem. 2004;50:2003-2011.
ABSTRACT | FULL TEXT  

Endoglin Controls Cell Migration and Composition of Focal Adhesions: FUNCTION OF THE CYTOSOLIC DOMAIN
Conley et al.
J. Biol. Chem. 2004;279:27440-27449.
ABSTRACT | FULL TEXT  

Screening for Pulmonary Arteriovenous Malformations
Morrell
Am. J. Respir. Crit. Care Med. 2004;169:978-979.
FULL TEXT  

CD105 is important for angiogenesis: evidence and potential applications
DUFF et al.
FASEB J. 2003;17:984-992.
ABSTRACT | FULL TEXT  

Contrast Echocardiography Remains Positive After Treatment of Pulmonary Arteriovenous Malformations
Lee et al.
Chest 2003;123:351-358.
ABSTRACT | FULL TEXT  

Neonatal pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasia
Koppen et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2002;87:F226-227.
ABSTRACT | FULL TEXT  

Cerebrovascular Manifestations in 321 Cases of Hereditary Hemorrhagic Telangiectasia
Maher et al.
Stroke 2001;32:877-882.
ABSTRACT | FULL TEXT  

A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1
Wallace and Shovlin
Thorax 2000;55:685-690.
ABSTRACT | FULL TEXT  

Pulmonary arteriovenous malformations: a clinical review
Iqbal et al.
Postgrad. Med. J. 2000;76:390-394.
ABSTRACT | FULL TEXT  

Value of Capillary Microscopy in the Diagnosis of Hereditary Hemorrhagic Telangiectasia
Mager and Westermann
Arch Dermatol 2000;136:732-734.
ABSTRACT | FULL TEXT  

Expression analysis of endoglin missense and truncation mutations: insights into protein structure and disease mechanisms
Lux et al.
Hum Mol Genet 2000;9:745-755.
ABSTRACT | FULL TEXT  

Rare diseases bullet 4: Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms
Shovlin and Letarte
Thorax 1999;54:714-729.
FULL TEXT  

Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease)
Caselitz et al.
Gut 1998;42:123-126.
ABSTRACT | FULL TEXT  

Pulmonary Arteriovenous Malformations and Hereditary Hemorrhagic Telangiectasia: Embolotherapy Using Balloons and Coils
White
Arch Intern Med 1996;156:2627-2628.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.